Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
01/01/2008 | US7314618 Novel nucleic acids encoding a fibroblast growth factor-23(FGF23) and proteins encoded thereby, mutations in which are associated with autosomal dominant rickets (ADHR). The invention further relates to methods of diagnosis of |
01/01/2008 | US7314615 IκB Kinase-β (IKKβ) binding antibodies and methods of using same |
01/01/2008 | US7314613 Covalently attached to a nonpeptide moiety; nucleic acids encoding the polypeptides; reducing the number of copies of a virus in infected cells |
12/27/2007 | WO2007149327A2 Composition and methods for improving the production of fermentation operations |
12/27/2007 | WO2007149287A2 Transfer factor compositions and methods |
12/27/2007 | WO2007148092A2 In vitro protein expression process comprising cκ fusion molecules |
12/27/2007 | WO2007147256A1 Fatty acid hydroxylases and uses thereof |
12/27/2007 | WO2007070315A3 Improved production of glycoproteins using manganese |
12/27/2007 | WO2007002008A3 Methods and compositions for expressing negative-sense viral rna in canine cells |
12/27/2007 | WO2006138363A3 Method for identifying modulators of keah6 useful for treating alzheimer's disease |
12/27/2007 | WO2005099390A3 Compositions and methods for reverse transcription |
12/27/2007 | WO2005069859A3 Compositions and methods for modulating dhr96 |
12/27/2007 | WO2003066824A3 Albumin-fused kunitz domain peptides |
12/27/2007 | US20070299247 Heterodimeric human cytokine receptor comprising interleukin-10 or orphan receptor components for use in treatment of cell proliferative, inflammatory and immune disorders |
12/27/2007 | US20070299014 Casein hydrolyzate, process for producing the same and use thereof |
12/27/2007 | US20070299006 Secreted by yeast; storage stability; nonimmunogenic; vaccine; long half-life; use for growth hormone deficiency in human or animal to stimulate meat production |
12/27/2007 | US20070298493 Transgenic animal cells containing endotheilial growth factor polypeptide for use as model system for treatment of cardiovascular and respiratory system disorders |
12/27/2007 | US20070298463 Variants of human glycoprotein hormone alpha chain: compositions and uses thereof |
12/27/2007 | US20070298462 Process for Obtaining Antibodies |
12/27/2007 | US20070298460 Novel receptor that causes cell death |
12/27/2007 | US20070298459 Death Domain Containing Receptor 6; severe combined immunodeficiency (SCID); adenosine deaminase deficiency, agammaglobulinemia Bruton's disease |
12/27/2007 | US20070298458 Method And Kit For Expressing Protein Under Regulation Of The Expression From Repeated Sequence Formed By Gene Amplification, And Transformant |
12/27/2007 | US20070298457 Soluble endoproteases for the in vitro processing of recombinant proteins |
12/27/2007 | US20070298455 Method For Preparing A Modified Host Cell |
12/27/2007 | US20070298448 Enrichment of Enzymatic Cleavage Products |
12/27/2007 | US20070298430 Ribosome Display or Mrna Display Method With Selection for Increased Stability of the Protein |
12/27/2007 | US20070298418 Molecules Involved in Protein Folding |
12/27/2007 | US20070298050 direct replacement of chloroplast Photosystem II (PSII) reaction center protein coding regions to achieve expression of recombinant protein above 5% of total protein; edible algae; mammary associated serum amyloid A3 (M-SAA3) |
12/27/2007 | US20070298049 Therapeutic Agent for Polycystic Ovary Syndrome (Pcos) |
12/27/2007 | US20070298039 Immunoglobulin specific to receptor protein DR5 for treatment of cancer, inflammatory or autoimmune diseases |
12/27/2007 | US20070298036 PRO71238 Polypeptides |
12/27/2007 | US20070298034 Sulfotyrosine specific antibodies and uses therefor |
12/27/2007 | DE202007012343U1 Aminosäure-Mineral-Peptid-Komplex, insbesondere quantenmechanisch modifiziert, als Rezeptur zur Regulierung der Haut Amino acid-mineral-peptide complex, in particular quantum-mechanically modified, as formulation for regulating skin |
12/27/2007 | CA2655544A1 Fatty acid hydroxylases and uses thereof |
12/27/2007 | CA2653061A1 Stabilized proteins |
12/26/2007 | EP1870467A1 Polypeptide hormone Phosphatonin |
12/26/2007 | EP1870466A2 Compositions and methods for therapy and diagnosis of prostate cancer |
12/26/2007 | EP1870465A2 Chemokine receptors 88-2B (CKR-3) and 88C and their antibodies |
12/26/2007 | EP1870460A1 Methods of producing proteins having triple-helix structure |
12/26/2007 | EP1870459A1 Methods for producing polypeptides by regulating polypeptide association |
12/26/2007 | EP1870457A1 Dipeptide crystals and process for production thereof |
12/26/2007 | EP1870456A1 Method for production of antibody directed against cell membrane surface antigen epitope and assaying method |
12/26/2007 | EP1870454A1 Method for producing dipeptide |
12/26/2007 | EP1870421A1 Novel anti-heparan sulfate antibody, method for detection of heparan sulfate, and kit for detection of heparan sulfate |
12/26/2007 | EP1869230A2 Method for purifying proteins |
12/26/2007 | EP1869192A2 Framework-shuffling of antibodies |
12/26/2007 | EP1869174A2 Lyase enzymes, nucleic acids encoding them and methods for making and using them |
12/26/2007 | EP1869173A2 Hydrolases, nucleic acids encoding them and methods for improving paper strength |
12/26/2007 | EP1868650A2 Covalent diabodies and uses thereof |
12/26/2007 | EP1868647A2 Antibodies that bind ov064 and methods of use therefor |
12/26/2007 | EP1427744B1 A system for antibody expression and assembly |
12/26/2007 | EP1401869B1 Molecules and methods for inhibiting shedding of kim-1 |
12/26/2007 | EP1116029B1 Apoptosis marker antibodies and methods of use |
12/26/2007 | EP0517829B2 Improved chimeric toxins |
12/26/2007 | CN101095053A Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84 |
12/26/2007 | CN101094916A Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for structure determination |
12/26/2007 | CN101094688A Multimeric constructs |
12/26/2007 | CN101094685A Use of flagellin in the immunotherapy of yersinia pestis |
12/26/2007 | CN101092640A Method for producing tabling monoclonal antibody of anti CD25 |
12/26/2007 | CN101092453A Therapeutic compounds comprised of anti-fc receptor binding agents |
12/26/2007 | CN101092446A Methods of synthesizing cell-free protein |
12/26/2007 | CN101091722A Injection of hydrolyzed peptide of liver |
12/26/2007 | CN100357448C Production method for iturin A and its homologues |
12/26/2007 | CN100357441C Yeast expressing system of recombined human nerve growth factor and process for preparing recombined human nerve grouth factor |
12/26/2007 | CN100357430C 纤维蛋白溶解活性多肽 Polypeptide fibrinolytic activity |
12/26/2007 | CN100357318C Mermaid photobacterium envelop protein W and coding sequence , its preparation method and uses |
12/25/2007 | US7312320 Neutralizing antibodies and methods of use thereof |
12/25/2007 | US7312317 P2Y4 antibodies |
12/25/2007 | US7312316 Novel polypeptides and nucleic acid molecules encoding those polypeptides; vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides fused to heterologous polypeptide sequences, and antibodies which bind to the polypeptides |
12/25/2007 | US7312315 PRO9742 antibodies |
12/25/2007 | US7312314 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocytes by contacting blood with polypeptide; cancer diagnosis |
12/25/2007 | US7312313 Nucleotide sequences coding polypeptide for use in the treatment of cell proliferative and tumor disorders |
12/25/2007 | US7312312 PRO6242 polypeptides |
12/25/2007 | US7312309 For release of tumor necrosis and or cellular differentation/proliferation of chrondrocytes by contacting blood w/polypeptides; cancer diagnosis |
12/25/2007 | US7312308 For stimulating release of tumor necrosis factor and/or cellular proliferation/differentiation of chondrocyte/pericyte/endothelial cells by contacting blood with pro-polypeptide; tumor diagnosis |
12/25/2007 | US7312303 Anti-PRO4980 antibodies |
12/25/2007 | US7312192 For treating diseases including diabetes |
12/25/2007 | US7312190 Pharmaceutical compositions of apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
12/25/2007 | US7312080 Plant resistance to insect pests mediated by viral proteins |
12/25/2007 | US7312079 host cell; expression vector; predicted osteoblast protein; for diagnosis, drug screening, clinical trial monitoring, the treatment of FAM3C-related disorders |
12/25/2007 | US7312060 Non-radioactive markers that facilitate the detection and analysis of nascent proteins translated within cellular or cell-free systems; preferred markers are dipyrrometheneboron difluoride |
12/25/2007 | US7312051 Polynucleotides encoding dendritic enriched secreted lymphocyte activation molecule |
12/25/2007 | US7312050 Nucleic acids encoding interphotoreceptor matrix proteins |
12/25/2007 | US7312049 Total amino acid stabilization during cell-free protein synthesis |
12/25/2007 | US7311918 Generation of rotavirus subunit proteins for use in vaccines and methods of providing protective immunity to vertebrates, including humans, against rotavirus infection or disease; providing cell-mediated immune response |
12/25/2007 | US7311917 Membrane proteins; fusion proteins; vaccines; kits |
12/25/2007 | US7311916 targets particular molecules that occur at the cell surface of HIV during viral entry into host cells; humoral response generated in vivo as a prophylactic measure in individuals to reduce or inhibit the ability of HIV to infect uninfected cells; mechanism of HIV cell entry |
12/25/2007 | US7311913 humanized monoclonal antibodies against human antihemophilic factor, used as antithrombotic agents, for treatment of strokes, ischemia, angina, necrosis, thrombosis, anemia, urogental disorders, thrombocytopenia or restenosis; cardiovascular disorders |
12/25/2007 | US7311909 PRO4348 antibodies |
12/21/2007 | WO2007145602A1 Process for the preparation of polymyxin b employing ( paeni ) bacillus polymyxa |
12/21/2007 | WO2007145267A1 Promoter capable of being expressed in root of plant |
12/21/2007 | WO2007144475A1 Method for producing lipase, transformed yarrowia lipolytica cell capable of producing said lipase and their uses |
12/21/2007 | WO2007143858A1 Dph2 gene deletion mutant and uses thereof |
12/21/2007 | WO2007104019A3 Hybrid protein with cox and pges enzyme activities |
12/21/2007 | WO2007104000A3 Hybrid protein that converts arachidonic acid into prostacyclin |
12/21/2007 | WO2007095243A3 Nucleic acid constructs and methods for producing altered seed oil compositions |
12/21/2007 | WO2007005647A3 Polynucleotides and polypeptides of the il-12 family of cytokines |
12/21/2007 | WO2006099592A3 Mannose immunogens for hiv-1 |
12/21/2007 | WO2004094593A3 Expanding the eukaryotic genetic code |
12/21/2007 | WO2004071405A3 Lactate dehydrogenase: a target and reagent for diabetes therapy |